Cargando…
Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436422/ https://www.ncbi.nlm.nih.gov/pubmed/34543859 http://dx.doi.org/10.1016/j.msard.2021.103263 |
| _version_ | 1783751989769797632 |
|---|---|
| author | Naser Moghadasi, Abdorreza |
| author_facet | Naser Moghadasi, Abdorreza |
| author_sort | Naser Moghadasi, Abdorreza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8436422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84364222021-09-13 Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed Naser Moghadasi, Abdorreza Mult Scler Relat Disord Article Elsevier B.V. 2021-11 2021-09-13 /pmc/articles/PMC8436422/ /pubmed/34543859 http://dx.doi.org/10.1016/j.msard.2021.103263 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Naser Moghadasi, Abdorreza Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title | Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title_full | Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title_fullStr | Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title_full_unstemmed | Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title_short | Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed |
| title_sort | importance of t-cell response to covid-19 vaccination in patients with multiple sclerosis treated by anti-cd20 therapies: new vaccines are required to be developed |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436422/ https://www.ncbi.nlm.nih.gov/pubmed/34543859 http://dx.doi.org/10.1016/j.msard.2021.103263 |
| work_keys_str_mv | AT nasermoghadasiabdorreza importanceoftcellresponsetocovid19vaccinationinpatientswithmultiplesclerosistreatedbyanticd20therapiesnewvaccinesarerequiredtobedeveloped |